KHRN.V - Khiron Life Sciences Corp.

TSXV - TSXV Delayed Price. Currency in CAD
Show:
Income Statement
Balance Sheet
Cash Flow
Annual

Income Statement

All numbers in thousands
Breakdown
ttm
2018-12-30
2017-12-30
2017-05-30
2016-05-30
Total Revenue
5,190
892
0
-
-
Cost of Revenue
-
594
0
-
-
Gross Profit
-
297
0
-
-
Operating Expenses
Research Development
-
-
-
-
-
Selling General and Administrative
28,221
20,194
3,765
45
60
Total Operating Expenses
30,368
20,194
3,765
45
60
Operating Income or Loss
-29,276
-19,896
-3,765
-45
-60
Interest Expense
-
-
-
-
-
Total Other Income/Expenses Net
-30
168
-15
0
0
Income Before Tax
-30,256
-19,728
-3,779
-45
-60
Income Tax Expense
-
79
0
-
-
Income from Continuing Operations
-30,334
-19,807
-3,779
-45
-60
Net Income
-30,334
-19,807
-3,779
-45
-60
Net Income available to common shareholders
-30,056
-19,528
-3,779
-45
-60
Reported EPS
Basic
-
-0.42
-0.14
-0.24
-0.24
Diluted
-
-0.42
-0.14
-0.24
-0.24
Weighted average shares outstanding
Basic
-
48,519
27,757
190
190
Diluted
-
48,519
27,757
190
190
EBITDA
-
-19,558
-3,764
-45
-60